Intra-Cellular Therapies Inc

NASDAQ:ITCI   3:59:54 PM EDT
43.11
+0.22 (+0.51%)
Products

Intra-Cellular Therapies Announces Publications Of Beneficial Effects Of Phosphodiesterase Type I Inhibition With Lenrispodun

Published: 09/20/2021 12:04 GMT
Intra-Cellular Therapies Inc (ITCI) - Intra-cellular Therapies Announces Publications Highlighting Beneficial Effects of Phosphodiesterase Type I Inhibition With Lenrispodun (iti-214) on Cardiovascular Function in Patients With Heart Failure and in Models of Accelerated Aging.
Intra-cellular Therapies - Results of Study Iti-214-104 Show That Lenrispodun, in a Phase 1/2a Study, is Well Tolerated.